Resolution Therapeutics

An Edinburgh and London cell therapy company developing macrophage treatments to repair damaged organs, starting with chronic liver disease.

About Resolution Therapeutics

Resolution Therapeutics develops cell treatments made from macrophages, immune cells that help the body repair tissue. Its first programme is an engineered macrophage therapy for people with liver cirrhosis, aiming to help them avoid liver failure and a transplant.

The company describes its work as developing cell treatments to repair organ damage, and it points to a shortage of options for people with chronic liver disease, where today's choices are mostly supportive care or transplant.

It was founded in 2020 as a spin-out from the University of Edinburgh's Centre for Regenerative Medicine, with the Scottish National Blood Transfusion Service. A jobs-board profile lists a London tag, but the address is the Centre for Regenerative Medicine at Edinburgh BioQuarter. A listing shows 80 employees, which is undated.

The founders include Professor Stuart Forbes, Director of the Centre for Regenerative Medicine, and John Campbell of the blood transfusion service. We found no culture details.

We found no open roles, graduate schemes or apprenticeships. Edinburgh BioQuarter and the University of Edinburgh's Centre for Regenerative Medicine are good places to look for research and lab roles.

What they do

• {'desc': 'Engineered immune cells that help repair damaged organs.', 'title': 'Macrophage cell therapy'}
• {'desc': 'First programme for compensated cirrhosis.', 'title': 'Liver disease programme'}
• {'desc': 'Built on Edinburgh regenerative medicine research.', 'title': 'Research partnerships'}

Key facts

• Founded 2020 as a University of Edinburgh spin-out
• Based at the Centre for Regenerative Medicine, Edinburgh BioQuarter
• Co-founder Prof Stuart Forbes
• 80 employees per jobs-board profile (undated)

Website: www.resolutiontx.com